Aspirin plus hydroxychloroquine to prevent preeclampsia in high-risk pregnancy
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether adding aspirin and hydroxychloroquine can lower the risk of preeclampsia during pregnancy in people considered high-risk. If you qualify, you may be assigned to take the study medicines to help protect you and the baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with a single baby (not twins or more) and age 19 to 50.
- You have at least one high-risk history, such as preeclampsia before, baby growth restriction before, or a prior stillbirth.
- You can and agree to enroll and sign informed consent.
- You have not joined another treatment study in the last 3 months (observational studies are usually okay).
- You do not have major pregnancy red flags at 11–13 weeks, like a major fetal birth defect.
- Your blood tests and medical conditions do not show severe kidney or liver problems, and your doctor agrees you’re medically suitable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.
This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.
This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.
This trial tests whether adding a daily blood-thinning injection (heparin) to low-dose aspirin helps prevent preeclampsia better than aspirin alone for pregnant women at high risk.
This trial tests whether a higher dose of aspirin (150 mg) works better than the standard dose (100 mg) to prevent preeclampsia, a serious pregnancy complication, in women with obesity who are at increased risk. If you are between 12 and 16 weeks pregnant with one baby and have a high BMI, you may be able to join.
This trial tests whether sending reminders to doctors helps them prescribe low-dose aspirin to pregnant patients at higher risk of preeclampsia (a serious pregnancy condition). Aspirin early in pregnancy may help prevent preeclampsia if you have risk factors.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.